MedPath

Solx, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

SOLX Gold Shunt for Refractory Glaucoma

Not Applicable
Completed
Conditions
Glaucoma
Glaucoma, Open Angle
Interventions
Device: SOLX Gold Shunt
First Posted Date
2011-01-25
Last Posted Date
2017-02-23
Lead Sponsor
SOLX, Inc.
Target Recruit Count
116
Registration Number
NCT01282346
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Glaucoma Associates of New York, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Ophthalmic Partners of Pennsylvania, Bala Cynwyd, Pennsylvania, United States

๐Ÿ‡จ๐Ÿ‡ฆ

Clarity Eye Institute, Vaughan, Ontario, Canada

and more 14 locations

SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma

Phase 3
Suspended
Conditions
Glaucoma
Glaucoma, Open Angle
Interventions
Device: Ahmed FP7 Glaucoma Valve
Device: SOLX Gold Shunt GMS-plus
First Posted Date
2006-09-29
Last Posted Date
2015-09-18
Lead Sponsor
SOLX, Inc.
Target Recruit Count
180
Registration Number
NCT00382395
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Tennessee / Hamilton Eye Institute, Memphis, Tennessee, United States

๐Ÿ‡ฎ๐Ÿ‡ณ

Bombay City Eye Institute & Research Centre, Mumbai, Maharashtra, India

๐Ÿ‡ฎ๐Ÿ‡ฑ

Chaim Sheba Medical Center, Tel Hashomer, Israel

and more 12 locations

SOLX Titanium Sapphire Laser for Trabeculoplasty

Phase 3
Completed
Conditions
Glaucoma
Glaucoma, Open Angle
Interventions
Device: SOLX Titanium Sapphire Laser (TiSaLT)
Device: Argon Laser Trabeculoplasty (ALT)
First Posted Date
2005-09-05
Last Posted Date
2010-01-29
Lead Sponsor
SOLX, Inc.
Target Recruit Count
120
Registration Number
NCT00145535
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Sourasky Medical Center, Tel Aviv, Israel

๐Ÿ‡บ๐Ÿ‡ธ

North Bay Eye Associates, Petaluma, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Glaucoma Associates of New York, New York, New York, United States

and more 7 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath